A new surgery choice of bilateral laminoplasty for symptomatic three or more-level lumbar canal stenosis in patients over 60 years old: a two-year retrospective study

对于60岁以上有症状的三节段或以上腰椎管狭窄患者,双侧椎板成形术是一种新的手术选择:一项为期两年的回顾性研究

阅读:2

Abstract

INTRODUCTION: Multi-level lumbar canal stenosis (LCS) in patients over 60 years is common and frequently complicated by significant comorbidities, making surgical decisions complex. While posterior lumbar interbody fusion (PLIF) is often used, bilateral laminoplasty offers a potential motion-preserving alternative. This study compares outcomes of bilateral laminoplasty versus PLIF for multi-level LCS in this elderly population. METHODS: This retrospective study included consecutive patients >60 years with ≥3-level LCS undergoing bilateral laminoplasty or PLIF at our center. Patients were followed for a mean of approximately 24 months. We first detailed the bilateral laminoplasty technique. Then, outcomes were assessed using Visual Analog Scale (VAS) for pain, Japanese Orthopaedic Association (JOA) score for neurological function, and Oswestry Disability Index (ODI) for quality of life. Perioperative parameters, complications, and comorbidities were analyzed. RESULTS: Fifty-one patients met inclusion criteria and surveyed (26 laminoplasty, 25 PLIF). Laminoplasty demonstrated significantly shorter operative time (1.8±0.4 vs. 3.2±0.7 hours) and reduced blood loss (102±38 vs. 318±204 ml) compared to PLIF. Transfusion rates were lower with laminoplasty (0% vs 52%). Both groups showed significant improvements in VAS, JOA, and ODI scores at final follow-up. Laminoplasty achieved significantly better final ODI scores. Comorbidity rates were high, but no serious complications were found. CONCLUSION: Bilateral laminoplasty is a safe and effective surgical option for patients over 60 years with multi-level LCS, offering comparable clinical improvements to PLIF while providing advantages of shorter operative time, significantly reduced blood loss and transfusion requirements. It represents a valuable motion-preserving alternative in this comorbid population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-025-08940-1.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。